842 related articles for article (PubMed ID: 16287793)
1. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
Hamaguchi M; Kojima T; Takeda N; Nakagawa T; Taniguchi H; Fujii K; Omatsu T; Nakajima T; Sarui H; Shimazaki M; Kato T; Okuda J; Ida K
Ann Intern Med; 2005 Nov; 143(10):722-8. PubMed ID: 16287793
[TBL] [Abstract][Full Text] [Related]
2. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome.
Hamaguchi M; Takeda N; Kojima T; Ohbora A; Kato T; Sarui H; Fukui M; Nagata C; Takeda J
World J Gastroenterol; 2012 Apr; 18(13):1508-16. PubMed ID: 22509083
[TBL] [Abstract][Full Text] [Related]
3. Fatty liver and the metabolic syndrome among Shanghai adults.
Fan JG; Zhu J; Li XJ; Chen L; Lu YS; Li L; Dai F; Li F; Chen SY
J Gastroenterol Hepatol; 2005 Dec; 20(12):1825-32. PubMed ID: 16336439
[TBL] [Abstract][Full Text] [Related]
4. Summaries for patients. The metabolic syndrome and fatty liver disease.
Ann Intern Med; 2005 Nov; 143(10):I70. PubMed ID: 16287788
[No Abstract] [Full Text] [Related]
5. Ultrasound evaluation and correlates of fatty liver disease: a population study in a Mediterranean area.
Chiloiro M; Caruso MG; Cisternino AM; Inguaggiato R; Reddavide R; Bonfiglio C; Guerra V; Notarnicola M; De Michele G; Correale M; Noviello MR; Misciagna G
Metab Syndr Relat Disord; 2013 Oct; 11(5):349-58. PubMed ID: 23758075
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.
Hamaguchi M; Kojima T; Takeda N; Nagata C; Takeda J; Sarui H; Kawahito Y; Yoshida N; Suetsugu A; Kato T; Okuda J; Ida K; Yoshikawa T
World J Gastroenterol; 2007 Mar; 13(10):1579-84. PubMed ID: 17461452
[TBL] [Abstract][Full Text] [Related]
7. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation.
Hamaguchi M; Kojima T; Itoh Y; Harano Y; Fujii K; Nakajima T; Kato T; Takeda N; Okuda J; Ida K; Kawahito Y; Yoshikawa T; Okanoue T
Am J Gastroenterol; 2007 Dec; 102(12):2708-15. PubMed ID: 17894848
[TBL] [Abstract][Full Text] [Related]
8. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
Younossi ZM; Stepanova M; Ong J; Yilmaz Y; Duseja A; Eguchi Y; El Kassas M; Castellanos-Fernandez M; George J; Jacobson IM; Bugianesi E; Wong VW; Arrese M; de Ledinghen V; Romero-Gomez M; Mendez-Sanchez N; Ahmed A; Wong R; Papatheodoridis G; Serfaty L; Younossi I; Nader F; Ziayee M; Afendy A;
Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1625-1633.e1. PubMed ID: 30476585
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
Yang S; Kwak S; Lee JH; Kang S; Lee SP
PLoS One; 2019; 14(11):e0224626. PubMed ID: 31682638
[TBL] [Abstract][Full Text] [Related]
10. Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women.
Kim HC; Choi SH; Shin HW; Cheong JY; Lee KW; Lee HC; Huh KB; Kim DJ
World J Gastroenterol; 2005 Sep; 11(34):5314-21. PubMed ID: 16149138
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum uric acid is an independent risk factor for nonalcoholic fatty liver disease in Japanese undergoing a health checkup.
Yamada T; Suzuki S; Fukatsu M; Wada T; Yoshida T; Joh T
Acta Gastroenterol Belg; 2010; 73(1):12-7. PubMed ID: 20458845
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome.
Hamaguchi M; Kojima T; Ohbora A; Takeda N; Fukui M; Kato T
World J Gastroenterol; 2012 Jan; 18(2):156-67. PubMed ID: 22253522
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease.
Tsai CH; Li TC; Lin CC
South Med J; 2008 Sep; 101(9):900-5. PubMed ID: 18708987
[TBL] [Abstract][Full Text] [Related]
14. Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease.
Powell EE; Jonsson JR; Clouston AD
Ann Intern Med; 2005 Nov; 143(10):753-4. PubMed ID: 16287799
[No Abstract] [Full Text] [Related]
15. Impact of fatty liver disease and metabolic syndrome on incident type 2 diabetes; a population based cohort study.
Mitsuhashi K; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukuda T; Fukui M
Endocr J; 2017 Nov; 64(11):1105-1114. PubMed ID: 28867686
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors associated with non-alcoholic fatty liver disease: a case-control study].
Caballería L; Arteaga I; Pera G; Rodríguez L; Alumà A; Auladell MA; Torán P
Med Clin (Barc); 2013 Sep; 141(6):233-9. PubMed ID: 23601740
[TBL] [Abstract][Full Text] [Related]
17. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period.
Hamabe A; Uto H; Imamura Y; Kusano K; Mawatari S; Kumagai K; Kure T; Tamai T; Moriuchi A; Sakiyama T; Oketani M; Ido A; Tsubouchi H
J Gastroenterol; 2011 Jun; 46(6):769-78. PubMed ID: 21302121
[TBL] [Abstract][Full Text] [Related]
18. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women.
Hamaguchi M; Kojima T; Ohbora A; Takeda N; Fukui M; Kato T
World J Gastroenterol; 2012 Jan; 18(3):237-43. PubMed ID: 22294826
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males.
Sogabe M; Okahisa T; Hibino S; Yamanoi A
J Gastroenterol; 2012 Mar; 47(3):293-9. PubMed ID: 22065161
[TBL] [Abstract][Full Text] [Related]
20. Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population.
Åberg F; Helenius-Hietala J; Puukka P; Färkkilä M; Jula A
Hepatology; 2018 Jun; 67(6):2141-2149. PubMed ID: 29164643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
